Cresset Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Buy |
|
|||||
|
2025
Q1 | $261K | Sell |
|
|||||
|
2024
Q4 | $579K | Sell |
|
|||||
|
2024
Q3 | $759K | Buy |
|
|||||
|
2024
Q2 | $641K | Buy |
|
|||||
|
2024
Q1 | $1.05M | Sell |
|
|||||
|
2023
Q4 | $624K | Buy |
|
|||||
|
2023
Q3 | $207K | Buy |
|
|||||
|
2023
Q2 | $227K | Buy |
|
|||||
|
2023
Q1 | $189K | Hold |
|
|||||
|
2022
Q4 | $198K | Sell |
|
|||||
|
2022
Q3 | $431K | Buy |
|
|||||
|
2022
Q2 | $265K | Sell |
|
|||||
|
2022
Q1 | $479K | Buy |
|
|||||
|
2021
Q4 | $369K | Buy |
|
|||||
|
2021
Q3 | $466K | Sell |
|
|||||
|
2021
Q2 | $600K | Buy |
|
|||||
|
2021
Q1 | $333K | Buy |
|